RASH
MCID: EXN002
MIFTS: 57

Exanthem (RASH)

Categories: Infectious diseases, Skin diseases

Aliases & Classifications for Exanthem

MalaCards integrated aliases for Exanthem:

Name: Exanthem 12 15 17
Exanthema 12 43
Rash 12 15
Rashes 42

Classifications:



External Ids:

Disease Ontology 12 DOID:0050486
ICD9CM 34 782.1
MeSH 43 D005076
SNOMED-CT 67 1806006
ICD10 32 R21
UMLS 71 C0015230

Summaries for Exanthem

MedlinePlus : 42 A rash is an area of irritated or swollen skin. Many rashes are itchy, red, painful, and irritated. Some rashes can also lead to blisters or patches of raw skin. Rashes are a symptom of many different medical problems. Other causes include irritating substances and allergies. Certain genes can make people more likely to get rashes. Contact dermatitis is a common type of rash. It causes redness, itching, and sometimes small bumps. You get the rash where you have touched an irritant, such as a chemical, or something you are allergic to, like poison ivy. Some rashes develop right away. Others form over several days. Although most rashes clear up fairly quickly, others are long-lasting and need long-term treatment. Because rashes can be caused by many different things, it's important to figure out what kind you have before you treat it. If it is a bad rash, if it does not go away, or if you have other symptoms, you should see your health care provider. Treatments may include moisturizers, lotions, baths, cortisone creams that relieve swelling, and antihistamines, which relieve itching.

MalaCards based summary : Exanthem, also known as exanthema, is related to wissler's syndrome and measles. An important gene associated with Exanthem is CCR6 (C-C Motif Chemokine Receptor 6), and among its related pathways/superpathways are ERK Signaling and PEDF Induced Signaling. The drugs Morphine and Vancomycin have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and breast, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A skin disease that is characterized by a rash that results from a variety of causes including bacteria, viruses, toxins, drugs and autoimmune disorders.

Wikipedia : 74 An exanthem is a widespread rash occurring on the outside of the body and usually occurring in children.... more...

Related Diseases for Exanthem

Diseases in the Exanthem family:

Bacterial Exanthem Viral Exanthem

Diseases related to Exanthem via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 983)
# Related Disease Score Top Affiliating Genes
1 wissler's syndrome 33.0 TNFRSF1B IL1RN CRP CD4
2 measles 31.7 TNF IL6 IL2 CD40LG
3 urticaria 31.4 TNF IL6 CRP CD40LG
4 drug reaction with eosinophilia and systemic symptoms 31.4 TNF CRP
5 purpura 31.4 TNF IL6 CRP CD40LG
6 rubella 31.3 TNFRSF1B TNF IL6 IL2 GPT CD40LG
7 contact dermatitis 31.3 TNF IL6 IL2 CD4
8 dermatitis 31.3 TNF IL6 IL2 CTLA4 CCR6
9 erythema multiforme 31.3 TNF IL6 IL2
10 meningitis 31.3 TNF IL6 IL2 CRP CD40LG ALB
11 mouth disease 31.3 IL6 ICOSLG H2AC18 CRP CCR6
12 secondary syphilis 31.3 CD8A CD40LG CD4
13 aseptic meningitis 31.2 TNF IL1RN CD40LG
14 mumps 31.2 TNFRSF1B TNF IL6 IL2 CD40LG
15 scarlet fever 31.2 TNF CRP CD40LG ALB
16 allergic hypersensitivity disease 31.2 TNF IL2 ICOSLG H2AC18 CTLA4 CD4
17 african tick-bite fever 31.2 TNF IL6 GPT CD40LG
18 epidemic typhus 31.1 GPT CRP CD8A CD40LG CD4
19 chickenpox 31.1 TNFRSF1B TNF IL6 IL2 ICOSLG CRP
20 kawasaki disease 31.1 TNF IL6 GPT CRP CD40LG CD4
21 vasculitis 31.1 TNFRSF1B TNF IL6 CTLA4 CRP CD40LG
22 poliomyelitis 31.0 TNF CD8A CD40LG CD4
23 spotted fever 31.0 TNF CTLA4 CD40LG
24 stomatitis 31.0 TNF IL6 IL2 IL1RN CD40LG CD4
25 lymphadenitis 31.0 TNF ICOSLG CRP CD4 CCR6
26 guillain-barre syndrome 31.0 TNFRSF1B TNF CD40LG ALB
27 smallpox 31.0 TNF IL2 IL1RN
28 coccidioidomycosis 31.0 CD40LG CD4 CCR6
29 syphilis 31.0 GPT CRP CD8A CD40LG CD4 CCR6
30 cat-scratch disease 30.9 CRP CD40LG CD4
31 spongiotic dermatitis 30.9 CD8A CD4 CCR6
32 neutropenia 30.9 IL6 IL1RN GPT CYP3A4 CRP
33 allergic contact dermatitis 30.9 TNF IL6 CD4
34 monkeypox 30.9 CD8A CD40LG CD4
35 drug allergy 30.9 GPT CYP3A4 CRP CD40LG CD4 ALB
36 thrombocytopenic purpura, autoimmune 30.8 ICOSLG CD40LG CD4 CCR6
37 parotitis 30.8 CRP CD40LG CD4 ALB
38 streptococcal toxic-shock syndrome 30.8 TNF IL6 IL2
39 vaccinia 30.8 TNF IL6 IL2 CTLA4
40 pleural empyema 30.8 CRP CD40LG CD4 ALB
41 erysipelas 30.8 TNF IL6 IL2 IL1RN CRP CD40LG
42 interstitial nephritis 30.8 ICOSLG CRP CD40LG ALB
43 pustulosis of palm and sole 30.8 TNFRSF1B TNF IL1RN CCR6
44 cervical adenitis 30.8 IL1RN CRP CD40LG
45 cutaneous lupus erythematosus 30.8 TNF IL6 CD40LG
46 adult-onset still's disease 30.8 TNF IL6 IL1RN CRP
47 pustulosis palmaris et plantaris 30.8 TNF CD40LG CCR6
48 uveitis 30.8 TNFRSF1B TNF IL6 IL2 CTLA4
49 lyme disease 30.8 TNF IL6 CRP CD40LG
50 schnitzler syndrome 30.8 IL1RN CRP CD40LG

Graphical network of the top 20 diseases related to Exanthem:



Diseases related to Exanthem

Symptoms & Phenotypes for Exanthem

MGI Mouse Phenotypes related to Exanthem:

45 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.34 ALB CCR6 CD40LG CRP CTLA4 EGFR
2 homeostasis/metabolism MP:0005376 10.31 ALB CCR6 CD274 CD4 CD40LG CRP
3 cellular MP:0005384 10.29 ALB CD274 CD4 CD40LG CD8A EGFR
4 endocrine/exocrine gland MP:0005379 10.26 ALB CD4 CD40LG CD8A CTLA4 EGFR
5 immune system MP:0005387 10.25 ALB CCR6 CD274 CD4 CD40LG CD8A
6 hematopoietic system MP:0005397 10.23 CCR6 CD274 CD4 CD40LG CD8A CTLA4
7 digestive/alimentary MP:0005381 10.19 ALB CD4 CTLA4 EGFR ERBB2 HRAS
8 mortality/aging MP:0010768 10.17 ALB CD274 CD4 CD40LG CD8A CTLA4
9 integument MP:0010771 10.15 CD274 CD4 CD40LG CD8A CTLA4 EGFR
10 neoplasm MP:0002006 9.86 ALB EGFR ERBB2 HRAS IL2 IL6
11 normal MP:0002873 9.81 ALB CCR6 CD4 CD8A CTLA4 EGFR
12 respiratory system MP:0005388 9.56 CTLA4 EGFR ERBB2 HRAS IL2 IL6
13 skeleton MP:0005390 9.36 CD274 CD40LG CTLA4 EGFR ERBB2 GPT

Drugs & Therapeutics for Exanthem

Drugs for Exanthem (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 708)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Morphine Approved, Investigational Phase 4 57-27-2 5288826
2
Vancomycin Approved Phase 4 1404-90-6 441141 14969
3
Enalaprilat Approved Phase 4 76420-72-9 6917719
4
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
5
Cefazolin Approved Phase 4 25953-19-9 656510 33255
6
Ceftaroline fosamil Approved, Investigational Phase 4 229016-73-3
7
Efavirenz Approved, Investigational Phase 4 154598-52-4 64139
8
Nevirapine Approved Phase 4 129618-40-2 4463
9
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
10
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
11
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
12
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
13
Sulfadiazine Approved, Investigational, Vet_approved Phase 4 68-35-9 5215
14
Cefpirome Approved Phase 4 84957-29-9 5479539
15
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
16
Moxifloxacin Approved, Investigational Phase 4 151096-09-2, 354812-41-2 152946
17
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
18
Polyestradiol phosphate Approved Phase 4 28014-46-2
19
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
20
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
21
Amifostine Approved, Investigational Phase 4 20537-88-6 2141
22
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
23
Bezafibrate Approved, Investigational Phase 4 41859-67-0 39042
24
Methyltestosterone Approved Phase 4 58-18-4 6010
25
Testosterone Approved, Experimental, Investigational Phase 4 58-22-0, 481-30-1 6013 10204
26
Testosterone enanthate Approved Phase 4 315-37-7 9416
27
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
28
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
29
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
30
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
31
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
32
Ledipasvir Approved Phase 4 1256388-51-8 67505836
33
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
34
Cocaine Approved, Illicit Phase 4 50-36-2 5760 446220
35
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
36
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
37
Topiramate Approved Phase 4 97240-79-4 5284627
38
Azithromycin Approved Phase 4 83905-01-5 55185 447043
39
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
40
Sulfamethoxazole Approved Phase 4 723-46-6 5329
41
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
42
Rifampicin Approved Phase 4 13292-46-1 5458213 5381226
43
Amantadine Approved Phase 4 768-94-5 2130
44
Bupropion Approved Phase 4 34911-55-2, 34841-39-9 444
45
Clarithromycin Approved Phase 4 81103-11-9 84029
46
Dexlansoprazole Approved, Investigational Phase 4 138530-94-6, 103577-45-3 9578005
47
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
48
Fenofibrate Approved Phase 4 49562-28-9 3339
49
Maraviroc Approved, Investigational Phase 4 376348-65-1 3002977
50
Praziquantel Approved, Investigational, Vet_approved Phase 4 55268-74-1 4891

Interventional clinical trials:

(show top 50) (show all 753)
# Name Status NCT ID Phase Drugs
1 Non-randomized Phase-IV-study to Investigate the Efficacy of FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema Unknown status NCT01315990 Phase 4 FOLFIRI + Cetuximab
2 Randomized Controlled Trial Comparing the Efficacy and Safety of Calmoseptine Ointment and Desitin Maximum Strength 40% Zinc Oxide Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Unknown status NCT02716415 Phase 4 Calmoseptine Ointment;Destin Maximum Strength 40% Zinc
3 Evaluation of Effectiveness and Safety of Oral Vancomycin in Treatment of Primary Sclerosing Cholangitis. Unknown status NCT02605213 Phase 4 Vancomycin;Placebo
4 Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® Unknown status NCT01553032 Phase 4 Erbitux®
5 Evaluation Whether Higher Retention Rate is in Those of Combined Methadone With N-Acetyl-Cysteine Compared to Those With Methadone Alone During a Six-month Study Unknown status NCT01047956 Phase 4 Methadone; NAC;Methadone
6 A Clinical Study on Anti-Hypertensive Agent (ACEi) and Heart Function Improvement Unknown status NCT01069042 Phase 4 Enalapril
7 An Open-Label Pilot Study to Compare the Efficacy of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids Unknown status NCT01583478 Phase 4
8 Comparison of Efficacy and Safety of the Postoperative Analgesia Methods for Supratentorial Craniotomy by Integrated Pulmonary Index (IPI) Unknown status NCT02929147 Phase 4 Morphine;Dexketoprofen;Placebo
9 ASSESSMENT OF GH-IGF1 AXIS AND TO STUDY RESPONSE TO GH THERAPY IN CHILDREN WITH CML IN REMISSION HAVING GH DEFICIENCY Unknown status NCT01901666 Phase 4 Growth Hormone
10 IDC 56: A Randomized Double-blinded Study Comparing Ceftaroline to Standard of Care Therapy With Cefazolin and Vancomycin as Surgical Prophylaxis for High Risk Orthopedic and Cardiac Surgeries Unknown status NCT02307006 Phase 4 Ceftaroline;Cefazolin / Vancomycin
11 Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration Completed NCT00280514 Phase 4 cefpirome and moxifloxacin administration
12 A Parallel, Evaluator-Blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Two Marketed Topical Skin Protectants Containing Zinc Oxide in Children With Diaper Rash Completed NCT00219466 Phase 4
13 A Multicenter, Randomized, Open-label, Controlled Study of Nevirapine (VIRAMUNE®) and a Short Course of Prednisone to Determine the Safety and Effectiveness of This Strategy in Preventing Nevirapine (VIRAMUNE®) Associated Rash. Completed NCT02184299 Phase 4 Nevirapine;Prednisone
14 A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster Completed NCT02152800 Phase 4 valacyclovir hydrocholoride
15 Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities Completed NCT00158041 Phase 4 Amifostine administered subcutaneously
16 Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™ Completed NCT02958345 Phase 4
17 Prospective 2-Year Longitudinal Study to Assess for Miconazole Resistance in Candida Spp. With Repeated Treatment Courses of 0.25% Miconazole Nitrate Ointment in Neonates and Infants up to 1 Year of Age With Recurrent Moderate-Severe Diaper Dermatitis Complicated by Cutaneous Candidiasis Completed NCT00702507 Phase 4 0.25 % Miconazole Nitrate Ointment
18 Early Effect Of Bezafibrate On Fibrinogen Levels, Inflammatory Response And Clinical Impact, In Patients With ST Elevation Acute Myocardial Infarction Completed NCT02291796 Phase 4 Bezafibrate
19 Physiologic Testosterone Replacement in Women With Hypopituitarism Completed NCT00144391 Phase 4 Transdermal Testosterone gel
20 Analgetic Effectiveness of Acupuncture When Compared to a Standardised Analgesic Regimen in the Treatment of Herpes Zoster Neuralgia Completed NCT00885586 Phase 4 gabapentine
21 Aloe Vera and Chlorhexidine as Preventive Oral Antiseptics Against the Appearance of Traumatic Oral Ulcers in Patients With Fixed Orthodontics: a Randomized Clinical Trial Completed NCT03633292 Phase 4 Antiseptic clorhexidine gel (Lacer, Barcelona, Spain);Master formula of aloe vera gel 80%
22 A Multi-center, Double-blinded Randomized Trial for Genotype Based Personalized Prescription of Nevirapine Completed NCT00986063 Phase 4
23 Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome Completed NCT02961998 Phase 4 Celecoxib;Sorafenib
24 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS) Completed NCT00200941 Phase 4 Topiramate
25 Pyrimethamine Plus Sulfadiazine Versus Trimethoprim Plus Sulfamethoxazole for Treatment of Toxoplasmic Encephalitis in AIDS Patients: A Randomized Controlled Trial. Completed NCT00367081 Phase 4 TMX-SMX (Bactrim(R));Pyrimethamine plus Sulfadiazine plus leucoverin
26 The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment Completed NCT01318356 Phase 4 Doxycycline;Placebo
27 A Retrospective Study to Compare the 3-Year Antiviral Efficacy of Nevirapine and Efavirenz in Combination With D4t and 3tc in 2NN Patients and of Trizivir Versus Trizivir Plus Nevirapine in CHARM Patients Completed NCT00127972 Phase 4 stavudine;lamivudine;nevirapine;efavirenz;trizivir
28 A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain: A Randomized Control Trial Completed NCT03221946 Phase 4 Diclofenac Sodium;Diclofenac sodium;Diclofenac
29 Comparison of Nevirapine Levels With and Without Dose Escalation in HIV-infected Patients Commencing Antiretroviral Therapy Who Are Also Receiving Rifampicin Based Anti-tuberculous Therapy Completed NCT00617643 Phase 4 Nevirapine without dose escalation;Nevirapine initiation with dose escalation
30 A Randomized, Double-blind, Placebo-controlled, Trial of Lamotrigine add-on Therapy in Outpatients With Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence Completed NCT00280293 Phase 4 Lamotrigine;Placebo
31 A Prospective, Randomized, Placebo-controlled Trial of Pre-transplant and Prompt Post-transplant Treatment With Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation Completed NCT01915082 Phase 4 Azithromycin;Ora-Plus
32 Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases Completed NCT02040116 Phase 4 Rituximab Infusion
33 Proteomic Profiling for Influenza Vaccination Completed NCT00133588 Phase 4
34 The Immunologic Effects of HCV Therapy With Fixed Dose Combination Ledipasvir/Sofosbuvir (HARVONI) in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs. Completed NCT02347345 Phase 4 Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
35 The Effect of Amantadine on Movement Disorder in Ataxia-Telangiectasia Completed NCT00950196 Phase 4 amantadine sulphate
36 A Comparison of Bupropion SR and Placebo for Smoking Cessation Completed NCT00176449 Phase 4 Bupropion SR;Placebo Oral Tablet
37 A Double Blinded Randomized Controlled Trial to Compare the Efficacy, Time to Onset, and Duration of Two Botulinum Type A Exotoxins (Onabotulinum Toxin A and Abobotulinum Toxin A) in the Treatment of "Crow's Feet." Completed NCT01529788 Phase 4 Right lateral orbital injection of Botox Cosmetic or Dysport;Left lateral orbital injection of Botox Cosmetic or Dysport
38 A Prospective, Randomized, Double Blind Study Comparing the Efficacy and Safety of Fentanyl Nasal Spray to Placebo as an Analgesic, in Patients Undergoing Outpatient Cystoscopic Procedures Completed NCT01708122 Phase 4 Fentanyl;saline
39 Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment Completed NCT00816140 Phase 4 Cravit based triple therapy;Klaricid based triple therapy
40 Efficacy and Safety of Extended Release Niacin-Fenofibrate Combination and Monotherapy for the Treatment of Atherogenic Dyslipidemia in Obese Females Completed NCT03615534 Phase 4 Fenofibrate
41 Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Highly Endemic Areas of Northeastern Brazil Completed NCT00403611 Phase 4 Praziquantel 60 mg/kg;Praziquantel 40 mg/kg
42 A Trial of Evaluating Additional Benefit of Cilostazol to Dual Antiplatelet Therapy in Patients With Long or Multi-vessel Coronary Artery Disease Underwent Biolimus-Eluting Stent Implantation Completed NCT01192724 Phase 4 Cilostazol;Aspirin;Clopidogrel
43 A Pilot Evaluation of the Pharmacokinetics, Efficacy and Safety of Switching From Efavirenz to Maraviroc Administered at 600mg Then 300mg Twice-daily in Patients Suppressed on an Efavirenz-containing Regimen as Initial Therapy Completed NCT01190293 Phase 4 Maraviroc
44 Evaluation of Ureteral Patency in the Post-indigo Carmine Era Completed NCT02677623 Phase 4 Pyridium;Sodium Fluorescein;Mannitol
45 Phenytoin as an Augmentation for SSRI Failures: A Controlled Study Completed NCT00146237 Phase 4 phenytoin
46 Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication Completed NCT03650543 Phase 4 amoxicillin clarithromycin omeprazole 1;amoxicillin clarithromycin omeprazole 2
47 A Study of Sertraline to Prevent PTSD Completed NCT00182078 Phase 4 Placebo;Sertraline
48 Pneumonia in Children: Aetiology, Ideal Antibiotic Duration, Quality of Life Completed NCT02258763 Phase 4 Amoxicillin-Potassium Clavulanate Combination;Placebo
49 Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial Completed NCT03052998 Phase 4 Ivermectin
50 EFFICACY OF KETAMINE-PROPOFOL COMBINATION FOR SHORT SURGICAL PROCEDURES Completed NCT01651988 Phase 4 Ketamina-Propofol Combination

Search NIH Clinical Center for Exanthem

Cochrane evidence based reviews: exanthema

Genetic Tests for Exanthem

Anatomical Context for Exanthem

MalaCards organs/tissues related to Exanthem:

40
Skin, Lung, Breast, Testes, Liver, T Cells, Bone

Publications for Exanthem

Articles related to Exanthem:

(show top 50) (show all 25859)
# Title Authors PMID Year
1
Atopic Dermatitis in Adults. 42
31757234 2020
2
Allergic Contact Dermatitis. 42
31757238 2020
3
Efficacy of Topical Botanical Treatment of Children With Mild to Moderate Atopic Dermatitis 42
31584783 2019
4
DRESS syndrome in response to Denosumab: First documented case report. 61
31890758 2020
5
Paraneoplastic bullous pemphigoid - A sign of clear cell renal carcinoma. 61
32021806 2020
6
Postmortem Chikungunya Diagnosis: A Case Report and Literature Review. 61
31977345 2020
7
Referral practices to dermatologists for the treatment of radiation dermatitis in the USA: a call for a multidisciplinary approach. 61
31768733 2020
8
The different faces of mycosis fungoides: results of a single-center study. 61
31782525 2020
9
Omenn Syndrome Identified by Newborn Screening. 61
32000930 2020
10
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma. 61
31678634 2020
11
Autoinflammatory Disorders with Perinatal Onset. 61
32000928 2020
12
18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin Rash. 61
31833924 2020
13
Ophthalmic manifestations of arbovirus infections in adults. 61
31679764 2020
14
Zika virus: an emerging challenge to public health worldwide. 61
31682478 2020
15
Clinical relevance of Zika symptoms in the context of a Zika Dengue epidemic. 61
31399372 2020
16
Efficacy of plasma exchange with a high dose of acyclovir for disseminated varicella infection. 61
31520251 2020
17
Quantitative Proteomics of the Endothelial Secretome Identifies RC0497 as Diagnostic of Acute Rickettsial Spotted Fever Infections. 61
31955791 2020
18
Treatment of Refractory Henoch-Schonlein Purpura (HSP) with Dapsone: A Systematic Review. 61
32024340 2020
19
Comparison of virological and serological methods for laboratory confirmation of rubella. 61
31927348 2020
20
Computational modelling and optimal control of measles epidemic in human population. 61
32035935 2020
21
A rare form of dermatomyositis associated with muscle weakness and normal creatine kinase level. 61
32033996 2020
22
Cholestatic hepatitis with concomitant nephrotic syndrome due to late syphilis in an immunocompetent 32-year-old man. 61
32029514 2020
23
[Gamasoidosis caused by Dermanyssusgallinae]. 61
31870576 2020
24
Multicenter Australian Study to Determine Criteria for Low- and High-Risk Penicillin Testing in Outpatients. 61
31604129 2020
25
A spatial-temporal analysis of organ-specific lupus flares in relation to atmospheric variables and fine particulate matter pollution. 61
32017464 2020
26
Dilemma in management of hemorrhagic myositis in dermatomyositis. 61
31872270 2020
27
Neonatal Acute Lymphoblastic Leukemia. 61
32011571 2020
28
[Clinical Analysis of Dasatinib and Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia]. 61
32027247 2020
29
Behçet's disease with invasive pulmonary aspergillosis and Aspergillus auriculatus infection: A case report. 61
32028403 2020
30
The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation. 61
31446673 2020
31
Dyskeratotic cells in persistent pruritic skin lesions as a prognostic factor in adult-onset Still disease. 61
32028422 2020
32
The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients. 61
31837440 2020
33
Management of immune checkpoint inhibitor-related dermatologic adverse events. 61
31814310 2020
34
Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017. 61
31997613 2020
35
[Exertional dyspnea, myalgia, petechiae of the lower extremities and pronounced gingivitis in a 64-year-old female patient]. 61
31915842 2020
36
Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease. 61
31147820 2020
37
Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency. 61
32030447 2020
38
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy. 61
32030732 2020
39
[Sebotropic drug eruption after ingestion of bee pollen]. 61
31831216 2020
40
Substance P receptor blocker, aprepitant, inhibited cutaneous and other neurogenic inflammation side effects of the EGFR1-TKI, erlotinib. 61
31853800 2020
41
Epidemiology, clinical features, and associated factors in 78 cases of lichen planus on black skin. 61
31630401 2020
42
Relations among motives, negative urgency, and mindfulness skills in college drinkers. 61
31645001 2020
43
Rare occurrence of central diabetes insipidus with dermatomyositis in a young male. 61
32031964 2020
44
AA amyloidosis secondary to adult onset Still's disease: About 19 cases. 61
31488308 2020
45
The use of intravenous immunoglobulin therapy in a tertiary pediatric hospital. 61
32020150 2020
46
A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies. 61
32020438 2020
47
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial. 61
31841354 2020
48
Conventional intensive versus LED intensive phototherapy oxidative stress burden in neonatal hyperbilirubinaemia of haemolytic origin. 61
30931835 2020
49
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer. 61
31853661 2020
50
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09). 61
31825714 2020

Variations for Exanthem

Expression for Exanthem

Search GEO for disease gene expression data for Exanthem.

Pathways for Exanthem

Pathways related to Exanthem according to GeneCards Suite gene sharing:

(show top 50) (show all 63)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.86 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
2
Show member pathways
13.66 TNFRSF1B TNF IL6 IL2 IL1RN HRAS
3
Show member pathways
13.65 TNFRSF1B TNF IL6 IL2 IL1RN ICOSLG
4
Show member pathways
13.47 ICOSLG HRAS ERBB2 EGFR CTLA4 CD8A
5
Show member pathways
13.37 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
6
Show member pathways
13.3 TNFRSF1B TNF IL6 IL2 IL1RN HRAS
7
Show member pathways
13.2 TNFRSF1B TNF IL6 IL2 HRAS ERBB2
8
Show member pathways
13.03 TNF IL6 IL2 HRAS ERBB2 EGFR
9
Show member pathways
12.98 TNFRSF1B TNF IL6 HRAS EGFR CD4
10
Show member pathways
12.97 TNFRSF1B TNF IL6 HRAS EGFR CD4
11
Show member pathways
12.81 TNFRSF1B TNF IL6 IL2 HRAS
12
Show member pathways
12.73 TNFRSF1B TNF IL6 IL2 EGFR CD40LG
13
Show member pathways
12.67 TNFRSF1B TNF HRAS EGFR CD40LG CD4
14
Show member pathways
12.66 TNF IL6 IL2 ICOSLG CTLA4 CD8A
15
Show member pathways
12.61 TNFRSF1B TNF IL2 ICOSLG HRAS CD40LG
16
Show member pathways
12.54 TNFRSF1B TNF HRAS ERBB2 EGFR
17
Show member pathways
12.53 TNF IL6 IL2 HRAS ERBB2 EGFR
18
Show member pathways
12.42 IL2 ICOSLG CTLA4 CD40LG